Lanean...
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke
BACKGROUND: Stroke is a leading cause of death and disability world wide. Thrombolysis with recombinant tissue plasminogen activator (rt‐PA) is licensed for treatment of acute ischaemic stroke in the early hours after symptom onset. It has been shown in randomised controlled trials (RCTs) and the 20...
Gorde:
| Argitaratua izan da: | Cochrane Database Syst Rev |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2013
|
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045424/ https://ncbi.nlm.nih.gov/pubmed/23728633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000514.pub3 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|